Add Yahoo as a preferred source to see more of our stories on Google. An illustration depicts cells in an Alzheimer’s-affected brain, with abnormal levels of beta amyloid protein clumping together to ...

A team at Kindai University in Osaka, Japan, fed ordinary L-arginine to fruit flies and mice engineered to develop ...

Dopamine could potentially treat Alzheimer’s by stimulating the production of an enzyme that breaks down beta-amyloid plaques, researchers say. Qi Yang/Getty Images When beta-amyloid plaques form, ...

Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually ...

A newly published Cochrane systematic review examining amyloid-beta-targeting monoclonal antibodies in Alzheimer's disease ...

Is there now ultrasound technology that can clear the brain of abnormal amyloid plaques in Alzheimer’s disease? The formation of amyloid plaques and neurofibrillary tangles are thought to contribute ...

Researchers at Kindai University found that the amino acid L-arginine, costing about $2 a month, reduced amyloid-beta plaques in both fruit fly and mouse Alzheimer’s models. The orally administered ...

Researchers at Lund University in Sweden have used the MAX IV synchrotron in Lund - the strongest of its kind in the world - to produce images that predate the formation of toxic clumps of ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. A Food and Drug Administration expert panel of advisors voted 11-0 ...

Set to launch this month, a recently approved blood test to detect biomarkers for Alzheimer’s disease could bring diagnosis into everyday clinical practice. In turn, this may support earlier ...

In the 1980s, researchers studying the autopsied brains of people with Alzheimer’s discovered that they were clogged with sticky plaques made from beta amyloid proteins and toxic tangles made of a ...